Statistics
Publications
16
Citations
384
H-Index
12
Active since
2014
Longlong Luo is an author at Institute of Pharmacology specializing in immunology, monoclonal antibodies, and antibody engineering.
Publications per year
2014–2024
16
16
PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy
Ning Shi, Yangyihua Zhou, Yujun Liu et al. · Frontiers in Immunology · 2022 · 42 citations · Full text
Pharmacy, Immunology, Oncology +17
A novel human anti‐AXL monoclonal antibody attenuates tumour cell migration
Yanting Duan, Longlong Luo, Chunxia Qiao et al. · Scandinavian Journal of Immunology · 2019 · 27 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 16